Sygnature Discovery delivers clinical candidate CORT125134 to Corcept
30 July 2015 | By Victoria White
Sygnature Discovery has delivered CORT125134, a glucocorticoid receptor antagonist in development for the treatment of Cushing’s syndrome, to Corcept...